Methylenedioxycathinone

Methylenedioxycathinone
Systematic (IUPAC) name
(±)-2-amino-1-(3,4-methylenedioxyphenyl)propan-1-one
Clinical data
Routes of
administration		 Oral, Insufflation, Rectal
Legal status
Legal status
Identifiers
CAS Number 80535-73-5 YesY
ATC code none
PubChem CID 57465250
Chemical data
Formula C10H11NO3
Molar mass 193.20 g·mol−1
  (verify)

3,4-Methylenedioxycathinone (also known as MDC, Nitrilone, Amylone and βk-MDA) is an empathogen and stimulant of the phenethylamine, amphetamine, and cathinone classes[1][2] and the β-keto analogue of MDA.[3]

Methylenedioxycathinone has been investigated as antidepressant and antiparkinson agent.[4]

See also

References

  1. ↑ Kei Zaitsu, Munehiro Katagi, Michiaki Tatsuno, Takako Sato, Hitoshi Tsuchihashi, Koichi Suzuki (July 2011). "Recently abused β-keto derivatives of 3,4-methylenedioxyphenylalkylamines: a review of their metabolisms and toxicological analysis". Forensic Toxicology 29 (2): 73–84. doi:10.1007/s11419-011-0111-8.
  2. ↑ Terry A Dal Cason, Richard Young, Richard A Glennon (December 1997). "Cathinone: An Investigation of Several N-Alkyl and Methylenedioxy-Substituted Analogs". Pharmacology Biochemistry and Behavior 58 (4): 1109–1116. doi:10.1016/S0091-3057(97)00323-7. PMID 9408221.
  3. ↑ Terry A Dal Cason (May 1997). "The characterization of some 3,4-methylenedioxycathinone (MDCATH) homologs". Forensic Science International 87 (1): 9–53. doi:10.1016/S0379-0738(97)02133-6.
  4. ↑ Peyton Jacob Iii, Alexander T Shulgin (12 December 1996). "Patent Application WO 1996039133 - Preparation of novel N-substituted-2-amino-3′,4′-methylenedioxypropiophenones as anti-depressant and anti-parkinsonism agents.". Retrieved 13 October 2015.

This article is issued from Wikipedia - version of the Friday, February 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.